Clinical Trial Update: Pharmacoscintigraphic Study to Evaluate Two Sildenafil Products [Phase 1]

View source ↗

Summary

A Phase 1 pharmacoscintigraphic study evaluating two sildenafil formulations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: N4 Pharma UK Ltd. | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED